| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 22.5 | 19.8 | 21.2 |
| Other income | 0.1 | 0.3 | 0.1 |
| Total income | 22.6 | 20.2 | 21.3 |
| Profit before exceptional items & tax | -1.6 | -1.4 | 1.5 |
| Profit before tax | -1.6 | -1.4 | 1.5 |
| Net profit | -2.3 | -1.7 | 1.2 |
| Operating margin | -7.1% | -6.9% | 7.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +6.10% |
|---|
BSE results filing, NSE: INTERCONTINENTAL. Figures extracted from the filing.
Medico Intercontinental Ltd: key numbers
- Share price
- ₹24.37
- Market cap
- ₹24.37 Cr
- Revenue (annual)
- ₹84.08 Cr
- Net profit (annual)
- ₹-3.20 Cr
- P/E (TTM)
- -6.1×Sector 41.4×
- Promoter holding
- 58.51%+1.36% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Intercontinental Ltd
All →Medico Intercontinental Annual General Meeting
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4 Cr